These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8617299)

  • 61. T-cell receptor analysis in Omenn's syndrome: evidence for defects in gene rearrangement and assembly.
    Brooks EG; Filipovich AH; Padgett JW; Mamlock R; Goldblum RM
    Blood; 1999 Jan; 93(1):242-50. PubMed ID: 9864167
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Soluble CD30 levels in plasma and cerebrospinal fluid in multiple sclerosis, HIV infection and other nervous system diseases.
    Navikas V; Martin C; Matusevicius D; Söderström M; Fredrikson S; Link H
    Acta Neurol Scand; 1997 Feb; 95(2):99-102. PubMed ID: 9059729
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Improvement in lung function is associated with a decrease in serum soluble CD30 in atopic infants.
    Kotaniemi-Syrjänen A; Delezuch W; Pelkonen AS; Malmström K; Malmberg LP; Punnonen K; Matinlauri IH; Mäkelä MJ
    Ann Allergy Asthma Immunol; 2015 Feb; 114(2):156-7. PubMed ID: 25492095
    [No Abstract]   [Full Text] [Related]  

  • 64. [The relation between clinical features of adult T-cell leukemia/lymphoma and the serum levels of soluble CD25 and CD30].
    Takemoto S; Pornkuna R; Hidaka M; Kawano F
    Rinsho Ketsueki; 2016 Jul; 57(7):848-53. PubMed ID: 27498727
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Selective gamma-chain T-cell receptor gene rearrangements in a patient with Omenn's syndrome: absence of V-II subgroup (V gamma 9) transcripts.
    Mathioudakis G; Good RA; Chernajovsky Y; Day NK; Platsoucas CD
    Clin Diagn Lab Immunol; 1996 Sep; 3(5):616-9. PubMed ID: 8877149
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Maternal serum soluble CD30 is increased in pregnancies complicated with acute pyelonephritis.
    Kusanovic JP; Romero R; Esoinoza J; Gotsch F; Edwin S; Chaiworapongsa T; Mittal P; Soto E; Erez O; Mazaki-Tovi S; Than NG; Friel LA; Yoon BH; Mazor M; Hassan SS
    J Matern Fetal Neonatal Med; 2007 Nov; 20(11):803-11. PubMed ID: 17853184
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment with cyclosporin A in a patient with Omenn's syndrome.
    Meyer-Bahlburg A; Haas JP; Haase R; Eschrich U; Wawer A; Frank L; Marsch WCh; Burdach S; Horneff G
    Arch Dis Child; 2002 Sep; 87(3):231-3. PubMed ID: 12193438
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An unusual case of severe combined immunodeficiency with hypereosinophilia.
    Dams ET; Mascart-Lemone F; Schandené L; van der Meer JW
    J Intern Med; 1997 Sep; 242(3):267-9. PubMed ID: 9350173
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Elevated serum and CSF levels of soluble CD30 during clinical remission in multiple sclerosis.
    McMillan SA; McDonnell GV; Douglas JP; Droogan AG; Hawkins SA
    Neurology; 1998 Oct; 51(4):1156-60. PubMed ID: 9781547
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Soluble CD30 antigen in human colostrum.
    Bertotto A; Vagliasindi C; Gerli R; Spinozzi F; Castellucci G; Fabietti G; Crupi S; Radicioni M; Cozzali R; Ferraro L; Niccoli A; De Rosa O; Lupi C; Brunelli R; Merluzzi A; Guadalupi D; Parente C; Pertici L; Serra M; Vaccaro R
    Biol Neonate; 1997; 71(2):69-74. PubMed ID: 9057989
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical and immunological findings in four infants with Omenn's syndrome: a form of severe combined immunodeficiency with phenotypically normal T cells, elevated IgE, and eosinophilia.
    Businco L; Di Fazio A; Ziruolo MG; Boner AL; Valletta EA; Ruco LP; Vitolo D; Ensoli B; Paganelli R
    Clin Immunol Immunopathol; 1987 Aug; 44(2):123-33. PubMed ID: 3111764
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The lymph node pathology of Omenn's syndrome.
    Martin JV; Willoughby PB; Giusti V; Price G; Cerezo L
    Am J Surg Pathol; 1995 Sep; 19(9):1082-7. PubMed ID: 7661282
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Omenn's syndrome--pathologic arguments in favor of a graft versus host pathogenesis: a report of nine cases.
    Jouan H; Le Deist F; Nezelof C
    Hum Pathol; 1987 Nov; 18(11):1101-8. PubMed ID: 3679186
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Engrafted maternal T cells in human severe combined immunodeficiency: evidence for a TH2 phenotype and a potential role of apoptosis on the restriction of T-cell receptor variable beta repertoire.
    Plebani A; Stringa M; Prigione I; Facchetti P; Ghiotto F; Airoldi I; Giacchino R; Cristina E; Porta F; Grossi CE; Pistoia V
    J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):131-4. PubMed ID: 9449515
    [No Abstract]   [Full Text] [Related]  

  • 75. Homozygous R396H mutation of the RAG1 gene in a Saudi infant with Omenn's syndrome: a case report.
    Al Balwi M; Al Ajaji S; Al Abdulkareem I; Hajeer A
    Cases J; 2009 Jul; 2():8391. PubMed ID: 19830075
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Omenn's Syndrome: A rare primary immunodeficiency disorder.
    Elnour IB; Ahmed S; Halim K; Nirmala V
    Sultan Qaboos Univ Med J; 2007 Aug; 7(2):133-8. PubMed ID: 21748095
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Omenn's syndrome and related combined immunodeficiency syndromes: diagnostic considerations in infants with persistent erythroderma and failure to thrive.
    Pupo RA; Tyring SK; Raimer SS; Wirt DP; Brooks EG; Goldblum RM
    J Am Acad Dermatol; 1991 Aug; 25(2 Pt 2):442-6. PubMed ID: 1832695
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Skin CD30(+) T cells and circulating levels of soluble CD30 are increased in patients with graft versus host disease.
    Amedei A; Pimpinelli N; Grassi A; Bella CD; Niccolai E; Brancati S; Benagiano M; D'Elios S; Bosi A; D'Elios MM
    Auto Immun Highlights; 2014 Jun; 5(1):21-6. PubMed ID: 26000151
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The pathology of Omenn's syndrome.
    Chilosi M; Facchetti F; Notarangelo LD; Romagnani S; Del Prete G; Almerigogna F; De Carli M
    Am J Surg Pathol; 1996 Jun; 20(6):773-4. PubMed ID: 8651359
    [No Abstract]   [Full Text] [Related]  

  • 80. Clinical Response to Anti-CD47 Immunotherapy Is Associated with Rapid Reduction of Exhausted Bystander CD4
    Jiang TT; Kruglov O; Lin GHY; Minic A; Jordan K; Uger RA; Wong M; Shou Y; Akilov OE
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.